Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Barrett Business Services
BBSI
$800M
| $15.6M | ﹤0.01% |
690,832
-8,932
| -1% | -$198K |
|
1902
Corcept Therapeutics
CORT
$11.9B
| $15.6M | ﹤0.01% |
1,291,300
-7,116
| -0.5% | -$99.1K |
|
1903
Weibo
WB
$1.88B
| $15.6M | ﹤0.01% |
336,992
+3,710
| +1% | +$174K |
|
1904
Scansource
SCSC
$1.06B
| $15.6M | ﹤0.01% |
421,684
-9,955
| -2% | -$338K |
|
1905
Mercer International
MERC
$33.8M
| $15.5M | ﹤0.01% |
1,263,518
+867
| +0.1% | +$10.6K |
|
|
AHRT
1906
AH Realty Trust
AHRT
$506M
| $15.5M | ﹤0.01% |
845,501
+155,192
| +22% | +$2.82M |
|
1907
MACOM Technology Solutions
MTSI
$23.5B
| $15.5M | ﹤0.01% |
582,154
-3,671
| -0.6% | -$87.7K |
|
1908
Liberty Media Series A
FWONA
$23.7B
| $15.5M | ﹤0.01% |
369,344
+34,164
| +10% | +$1.34M |
|
1909
Fate Therapeutics
FATE
$294M
| $15.5M | ﹤0.01% |
790,630
+94,310
| +14% | +$1.5M |
|
1910
Zscaler
ZS
$30.4B
| $15.4M | ﹤0.01% |
331,886
+10,302
| +3% | +$478K |
|
1911
Chord Energy
CHRD
$7.35B
| $15.4M | ﹤0.01% |
4,710,678
-752,470
| -14% | -$2.15M |
|
1912
Usana Health Sciences
USNA
$252M
| $15.3M | ﹤0.01% |
195,356
-7,119
| -4% | -$524K |
|
1913
Agios Pharmaceuticals
AGIO
$2B
| $15.3M | ﹤0.01% |
320,839
+29,421
| +10% | +$1.11M |
|
1914
Middlesex Water
MSEX
$1.11B
| $15.3M | ﹤0.01% |
240,139
-1,277
| -0.5% | -$80.9K |
|
1915
Central Pacific Financial
CPF
$1B
| $15.3M | ﹤0.01% |
515,994
-4,528
| -0.9% | -$132K |
|
1916
B&G Foods
BGS
$299M
| $15.3M | ﹤0.01% |
851,002
-20,103
| -2% | -$338K |
|
1917
Perdoceo Education
PRDO
$1.99B
| $15.2M | ﹤0.01% |
828,209
-122,221
| -13% | -$1.99M |
|
1918
Signet Jewelers
SIG
$3.6B
| $15.2M | ﹤0.01% |
698,165
-25,869
| -4% | -$459K |
|
|
DRNA
1919
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $15.1M | ﹤0.01% |
687,251
-191
| -0% | -$3.84K |
|
|
EBIX
1920
DELISTED
Ebix Inc
EBIX
| $15.1M | ﹤0.01% |
452,604
-9,507
| -2% | -$351K |
|
1921
OneMain Financial
OMF
$7.51B
| $15M | ﹤0.01% |
356,962
-32,974
| -8% | -$1.33M |
|
1922
Alkermes
ALKS
$8.3B
| $15M | ﹤0.01% |
736,832
-189,210
| -20% | -$3.76M |
|
|
POLY
1923
DELISTED
Plantronics, Inc.
POLY
| $15M | ﹤0.01% |
549,308
-89,781
| -14% | -$2.7M |
|
1924
Vanguard Real Estate ETF
VNQ
$39.1B
| $15M | ﹤0.01% |
161,421
-9,195
| -5% | -$851K |
|
1925
St. Joe Company
JOE
$3.89B
| $15M | ﹤0.01% |
755,117
-23,202
| -3% | -$430K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.